Hematopoietic cell transplantation (HCT) is an intensive treatment resulting in disease control however subsequent psychosocial distress is common. Screening for psychosocial risk factors that contribute to morbidity is underutilized; moreover, the value in screening is uncertain. We performed a retrospective study of 395 HCT patients who were screened for psychosocial risk using the Transplant Evaluation Rating Scale (TERS). Patients were classified by psychosocial risk as no-risk (TERS = 26.5, 52%) vs. at-risk (TERS > 26.5, 48%), with at-risk patients stratified by cumulative deficits into mild risk (TERS = 27-35.5, 39%) and moderate risk (TERS > 35.5, 9%). At-risk patients were more likely to be readmitted within 90 days (mild risk HR = 1.62, p = 0.02; moderate risk HR = 2.50, p = 0.002). Prior psychiatric history (HR = 1.81, p = 0.002) and poor coping skills (HR = 1.64, p = 0.04) also influenced readmission. At-risk patients were more likely to be readmitted for infection (no-risk = 12% vs. at-risk = 25%, p = 0.002). Pre-HCT screening with the TERS did not predict survival or length of stay although at-risk patients are at a heighted risk of readmission. Implementing strategies to reduce readmission in higher risk patients is warranted.
Introduction
Hematopoietic Cell Transplant (HCT) is an intensive, potentially curative treatment modality that can result in psychological distress associated with high rates of depression, anxiety, and post-traumatic stress disorder [1] [2] [3] [4] [5] [6] [7] [8] . As a result, pre-transplant psychosocial screening, i.e., the identification of psychosocially vulnerable patients, has been integrated into the HCT process at nearly all transplant centers [9] although the value of screening is uncertain. Psychosocial screening broadly includes an assessment of an individual's resilience, mental health, compliance, social support, coping and health behaviors and offers information to clinicians to guide therapeutic interventions and contribute to eligibility decisions. Several screening tools are available including the Transplant Evaluation Rating Scale (TERS) [10] , the Psychosocial Assessment of Candidates for Transplantation scale, and the Stanford Integrated Psychosocial Assessment for Transplantation [11] [12] [13] . These screening tools are aggregate measures of specific psychosocial risk factors. The lack of evidence-based guidelines for psychosocial screening has lead to variable utilization of different formal and informal psychosocial assessments across transplant centers [14] [15] [16] .
HCT clinicians are highly variable in both approach and willingness to proceed with transplant based on perceived psychosocial risk [17] . Furthermore, the utility of psychosocial screening at predicting transplant morbidity is uncertain. Psychosocial vulnerability has been associated with longer length of stay (LOS) [18, 19] , increased rates of graft-versus-host-disease [20] , increased rates of infection [21] , and worse overall survival (OS) [18, [22] [23] [24] [25] [26] [27] [28] . However there is significant discordance among published data [6, 8, 29] . As most centers utilize tools which are aggregate measures, it is unknown which particular psychosocial risk factors are most important for outcomes, and what role psychosocial interventions can have at mitigating risk [30] . Here we analyzed the utility of the TERS and its subscale scores at predicting clinical outcomes including hospital readmission, length of inpatient stay, and OS in HCT patients.
Materials and methods

Patients
We performed a retrospective study utilizing data collected from 395 consecutive HCT patients at a single center between October 2013 and April 2015 who underwent pre-HCT psychosocial screening using the TERS. The scoring was performed in person by two social workers prior to HCT as part of the overall psychosocial evaluation. Scores were screened for mathematical accuracy and clerical errors prior to statistical analysis but were not altered in any other way. TERS scoring was not independently verified by secondary review of the EMR or subsequent interviews. TERS scoring and interpretation were available for clinicians as part of the standard pre-transplant evaluation. There are no pre-defined eligibility criteria with respect to TERS scoring, disease status or end-organ function beyond clinician judgment at our institution. Eligible patients with higher TERS scores were provided resources identified through our social workers though no formal protocol exists to direct allocation. All patients are required to live within specified distances from the HCT center following HCT for a specific timeframe. Approval from The Ohio State University Comprehensive Cancer Center Institutional Review Board was obtained to perform this study, in accordance with the principles of the Declaration of Helsinki.
The TERS (See Supplemental Fig. 1 ) is a validated (κ = 0.89-0.98, α = 0.76, p = <0.001) [31] screening tool which has been shown to accurately identify psychosocially vulnerable patients according to Minnesota Multiphasic Personality Inventory criteria in HCT and other transplant populations [11, 32] . The TERS score is an aggregate of ten different domains thought to be important in adjusting to HCT. Component domains of the scale include: Axis I diagnosis from Diagnostic and Statistical Manual of Mental Disorders (DSM) IV-Revised (R), Axis II diagnosis from DSM-IV-R, substance use/abuse, compliance, health behaviors, quality of family/social support, coping history, coping with disease and treatment, affect quality, and mental status. Each domain is rated on a three-level severity scale indicating minimal, moderate, or severe concerns. Each rating is multiplied by an a priori assigned weight from 1 to 4 based on relative importance as perceived by the initial authors of the scale [11] . These weighted scores are summed to produce the final score. Scores range from a minimum of 26.5 to a maximum of 79.5 where higher scores represent higher psychosocial vulnerability [11] .
For our analysis, patients were classified according to psychosocial risk as no-risk (TERS = 26.5) versus at-risk (TERS > 26.5). Patients classified as no-risk had no identified risk factors by the TERS scoring and received the lowest possible score of 26.5. We further stratified at-risk patients based on cumulative deficits (mild risk [TERS = 27-35.5] and moderate risk [TERS > 35.5]). These cutpoints were established from traditional institutional categories derived from early TERS data. Although these cutpoints are not validated, a TERS score of 35.5 fits within published means of comparative samples [11, 31] . TERS scores were obtained through an institutional database of all HCT patients and individual TERS subcategories were identified by review of the notes in the EMR.
Patients were also classified into subcategories using the standard ten TERS component domains if they had moderate and/or severe concerns in one specific domain. During initial TERS scoring at our institution, there was no distinction made between "Axis I" and "Axis II" psychiatric diagnosis or between "coping history" and "coping with disease and treatment." These separate TERS domains were therefore combined into "Psychiatric history" and "Coping" respectively for analysis.
Patients were assigned to four disease categories (multiple myeloma, acute leukemia [encompassing acute myeloid leukemia, acute lymphocytic leukemia, and chronic myeloid leukemia], lymphoma, and other [which included aplastic anemia, amyloidosis, and germ cell tumors]) based on their primary indication for HCT. Information from the HCT database and the EMR was obtained to describe demographics, disease, and HCT variables. Hospital readmission was identified through the institutional database and verified through review of the EMR. The cause for readmission was identified by review of the EMR discharge summary. Readmission exclusively for inpatient rehabilitation was excluded.
Statistics
Patients' baseline characteristics were summarized using descriptive statistics and compared between TERS groups using Fisher's exact test or Wilcoxon rank sum test for categorical and continuous variables respectively. The primary endpoint, time to hospital readmission, was calculated from the date of transplant discharge to the date of readmission, censoring patients without an event at last follow-up or 90 days post-HCT discharge. Treating death from any cause as the competing risk, cumulative incidence rates (CIR) of readmission were estimated using cumulative incidence function and compared between TERS groups by the Gray's test. Proportional sub-distribution hazards model was built to correlate variables with hospital readmission. Univariable models were first fit, and then multivariable models were built including all variables from univariable analysis with p < 0.2. As the HCT-CI and the TERS include overlapping domains, the final models contained both scores regardless of statistical significance and all other variables with p < 0.05. Covariates included age, gender, race, primary disease, remission status, KPS, HCT-CI, transplant type, and graft source. Overall survival was calculated from the date of HCT until death, censoring patients who were alive at last follow-up. Estimate for OS and Nonrelapse mortality (NRM) was obtained using the Kaplan-Meier method and compared between TERS groups by the log-rank test. LOS was defined as the length of inpatient admission during HCT, and a generalized linear model was used to estimate the association between LOS and TERS score and other clinical factors. All tests were two-sided, statistical significance was set at α = 0.05. SAS 9.4 and S-PLUS 8.1 were used for statistical analyses.
Results
Patient characteristics
Baseline demographics are presented in Table 1 . (See supplemental Tables 1 and 2 for demographics separated by autologous and allogeneic HCT.) The median age of patients was 57 (range 20-77). In total, 58% were male; 90% were white. Patients underwent autologous (n = 218, 55%) and allogeneic (n = 177, 45%) HCT for acute leukemia (n = 140, 35%), multiple myeloma (n = 134, 34%), lymphoma (n = 93, 24%), and other indications (n = 28, 7%). Nearly half of patients (n = 190, 48%) had identified psychosocial risk factors with 39% (n = 154) classified as mild risk and 9% (n = 36) classified as moderate risk. The mean TERS score of the entire cohort was 29.6 (standard deviation (SD) = 4.6). The means for mild risk and moderate risk patients were 31.0 (SD = 2.1) and 41.0 (SD = 5.0), respectively. Characteristics were similar among TERS groups with respect to race, gender, disease, remission status, and type of HCT. Patients with higher TERS scores tended to be younger (moderate risk [median age = 50.5 years] vs. no-risk or mild risk [median age = 58.0 years], p = 0.04) and have worse KPS (moderate risk (31) 13 (36) Lymphoma 93 (24) 51 (25) 37 (24) 5 (14) Other 28 (7) 10 (5) 15 (10) 3 (8) Type of HCT, n (%) 
Outcomes
The CIR of readmission at day 90 was significantly higher among patients with higher psychosocial risk (no-risk 23%, mild risk 35%, moderate risk 47%, Gray's test p-value = 0.002) (Fig. 1a) . Autologous cell transplant: Demographics were similar to the entire population, however the association between younger patients and higher TERS scores was no longer significant for autologous recipients (see Supplemental Table 1 ). The CIR of readmission by aggregate TERS score for patients undergoing autologous transplantation (n = 218) is presented in Fig. 1b . The 90-day CIR of readmission for moderate risk group (32%) was significantly higher than the mild risk (17%) and no-risk (11%) group (p = 0.05). Univariable and multivariable proportional sub-distribution hazards models for readmission are presented in Table 3 . In univariable analysis, treating TERS as a continuous variable patients receiving an autologous HCT, and (c) patients receiving an allogeneic HCT. In analyzing all patients together, there is significant separation between the three groups with respect to incidence of readmission. For patients receiving an autologous HCT, there is a significant difference between the moderate risk patients and the other two groups. For patients receiving an allogeneic HCT, there is a significant difference between no-risk patients and the other two groups was no longer significant to predict readmission (p = 0.08).
In multivariable analysis, after controlling for HCT-CI, there was no significant difference in readmission when comparing mild risk patients to those with no risk (HR = 1.38 [95% CI: 0.65-2.92], p = 0.40). Moderate risk patients, however, were over three times more likely to be readmitted than no-risk patients (HR = 3.22 [95% CI: 1.15-9.04], p = 0.03). Allogeneic cell transplant: Demographics were similar to the entire population, however the association between KPS and higher TERS scores was no longer significant for allogeneic recipients (See Supplemental Table 2 ). The CIR of readmission by aggregate TERS score for patients undergoing allogeneic transplantation (n = 177) is presented in Fig. 1c . The 90-day CIRs of readmission for moderate (65%) and mild (57%) risk group were significantly higher than the no-risk (37%) group (p = 0.03). Table 4 presents the univariable and multivariable proportional hazards models for readmission for this population. TERS was significant as a continuous variable, representing a 3-8% increase in the risk of readmission with each increased point on the TERS. In multivariable analysis, after controlling for HCT-CI, moderate risk patients were nearly twice as likely (HR = 1.97 [95% CI: 1.06-3.68], p = 0.03) and mild risk patients 1.6 times as likely (HR = 1.64 [95% CI: 1.02-2.64], p = 0.04) to be readmitted than no-risk patients.
TERS subcategories: The distribution of TERS subcategory scores and the cumulative incidence rate of readmission at day 90 by TERS subcategory are presented in Table 5 . Psychiatric conditions (24%), poor health behaviors (16%), and poor coping skills (13%) were the most common identified risk factors while substance abuse (7%) and non-compliance (2%) were less frequent. Patients who were identified to have Axis I or II disorders were significantly more likely to be readmitted than patients without these conditions (HR = 1.81 [95% CI: 1.25-2.64], p = 0.002). Additionally, patients who were identified to have poor coping skills (HR = 1.64 [95% CI: 1.03-2.61], p = 0.04) were at higher risk of readmission. All other subcategories were not significantly correlated with readmission. Patients identified to be non-compliant prior to HCT (2% of all patients) were very likely to be readmitted. Five out of nine patients (56%) were readmitted within 90 days; however, this was not found to be significant likely due to small sample size (HR 2.25 [95% CI: 0.97-5.22], p = 0.06).
Cause of Readmission: Patients were most commonly readmitted for infection (62%), GVHD (25%), and relapse (11%). Psychosocially at-risk patients were more likely to be readmitted for infection than patients without identified [10] . Readmission for other causes did not differ significantly between TERS groups. OS, NRM, and LOS: There was no significant difference in OS or NRM between TERS groups for all patients (OS p = 0.51, NRM p = 0.95), autologous HCT recipients (OS p = 0.34, NRM p = 0.06) or allogeneic HCT recipients (OS p = 0.60, NRM p = 0.33) (Supplemental Figures 2 and 3,  respectively) . The correlation between TERS score and length of stay was also not significant in either univariable or multivariable models.
Discussion
We observed that pre-HCT psychosocial risk, as measured by the TERS, predicted hospital readmission for HCT recipients, independent of disease, comorbidities or type of transplant. Identifying psychosocial risk factors that contribute to hospital readmissions is important for both the patient and clinician in order to optimize management. Previous studies have shown an association between hospital readmissions and increased mortality for HCT patients [33] [34] [35] . We did not find a relationship between OS or NRM and psychosocial risk. Although this data supports the conclusion that psychosocial risk does not significantly influence survival in HCT patients, further studies are necessary particularly given the limited power of our study and relative short follow-up period. It is also important to note that this study was not designed to address eligibility for HCT. Studies comparing the outcomes of psychosocially vulnerable patients who undergo HCT to those who do not undergo HCT are needed to justify eligibility criteria and inform referral guidelines.
Depression has previously been shown to be associated with worse outcomes in HCT [36] [37] [38] and cancer in general [39, 40] . The work presented here suggests that all mood disorders confer a disproportionate risk of hospital readmission while also demonstrating the cumulative risk of readmission with additional psychosocial risk factors. Poor coping ability identified prior to HCT also predicts hospital readmission. Targeted interventions in these at-risk patients may substantially improve patient outcomes following transplant.
The association between psychosocial risk and hospital readmission held across type of transplant (autologous and allogeneic) with some important caveats. There was no difference in hospital readmission between no-risk and mild risk patients receiving an autologous transplant. This may be due to the presumed lower amount of distress caused by autologous transplantation. There was a marked difference, however, between lower risk patients and moderate risk patients, illustrating the particular vulnerability of these patients after autologous HCT. In contrast in allogeneic transplantation, hospital readmission for mild risk and CR complete remission, HCT-CI hematopoietic cell transplant comorbidity index, PD progressive disease, PR partial response, PS performance status, SD stable disease, TERS transplant evaluation rating scale moderate risk patients were similar and no-risk patients faired much better than either higher risk group. These findings may inform HCT center policies to better allocate resources to support these patients. Our data have certain limitations, including the retrospective, single-institution design and short follow-up period. Our population is also particularly racially homogenous. Ninety percent of patients were white which limits analysis of the influence of race on outcomes and potentially the application of this data to other racial or ethnic groups. Further, most patients in our study had very low psychosocial risk according to the TERS while other studies [11, 18, 31, 32] have included patients with significantly higher risk. This difference may be explained by several factors. All patients analyzed within this study received a transplant. Patients "unfit" or "ineligible" for transplant due to disease or other factors who may have had higher TERS scores were not included in this study. Further, higher risk patients may not have been referred to our tertiary HCT center due to the perceived concern for worse overall outcomes [41] . Disparities in access to HCT due to age, sex, race, and insurance status have been described [42] and are likely present in psychosocial domains as well.
Exploring how psychosocial risk is associated with hospital readmission in HCT is crucial in order to implement interventions. Non-compliance, driven by psychological issues [43] , limited financial resources, poor insight, or inadequate social support is often cited anecdotally as the root of these poor outcomes in transplant patients. This study lends limited support to this theory. Rigorously quantifying non-compliance is a significant obstacle to understanding its impact on HCT. Patients scored by the TERS are classified as having minimal, moderate, or severe concerns of non-compliance based on the scorers' perception and patient history though no assessment was made to confirm that a history of noncompliance prior to HCT correlated with non-compliance following HCT. Patients identified pre-HCT by the TERS with a concern of non-compliance had a very high hazard ratio of hospital readmission (56% of these patients were readmitted in 90 days). Likely because of the small sample size (2% of all patients), this was not statistically significant.
Psychosocially vulnerable patients have been previously reported to have poorer health in general [44] [45] [46] [47] which one may postulate contributes to worse outcomes. In our study, psychosocial vulnerability was correlated with both HCT-CI and KPS. However on multivariable analysis, we found that HCT-CI and KPS were not significantly associated with increased readmission. This indicates the independent predictive ability of psychosocial vulnerability on hospital There is evidence to suggest that psychosocial factors impact immune response in general [48, 49] and in HCT patients [50] . Infections are common in the transplant population and therefore identifying a clear relationship is difficult. However, when compounded with the immunosuppressive regimen following HCT, any further immune compromise from psychosocial distress may lead to higher rates of infection, hospital readmissions, and worse outcomes. Pre-HCT screening with the TERS can identify patients who are at a higher risk of readmission following HCT. Patients with multiple risk factors, mood disorders and poor coping skills are especially vulnerable. As a result of this data, our center has implemented a multidisciplinary approach to institute additional support mechanisms such as psychiatry, counseling/psycho-oncology services, and increased healthcare navigation for at-risk patients. Although further studies are needed to validate the efficacy of these services, HCT centers should review institutional practices for screening and supporting psychosocially vulnerable patients. Interventions should start prior to and continue beyond HCT. We believe that by identifying psychosocially vulnerable patients prior to HCT steps can be taken to abrogate the increased risk of adverse events and improve overall outcomes. % is a percentage of all 395 patients c Includes TERS categories "DSM-IV-R Axis I" and "DSM-IV-R Axis II" d Includes TERS categories "Prior history of coping" and "Coping with disease treatment" e This category refers primarily to the influence of fear and anxiety on patients' well-being prior to HCT. See Futterman et al. for broader description CIR cumulative incidence rate, CI confidence interval
